Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-14-000035
Filing Date
2014-01-29
Accepted
2014-01-29 21:34:56
Documents
1
Period of Report
2014-01-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 22130
  Complete submission text file 0001250853-14-000035.txt   23791
Mailing Address 400 OYSTER POINT BLVD. SAN FRANCISCO CA 94080
Business Address
Ahn Mark J (Reporting) CIK: 0001296543 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 14558511

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations